Cover Image

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

Heterozygous mutations of the receptor CD95 (Fas/Apo-1) are associated with defective lymphocyte apoptosis and a clinical disease characterized by lymphadenopathy, splenomegaly, and systemic autoimmunity. From our cohort of 11 families, we studied eight patients to define the mechanisms responsible...

Full description

Saved in:
Bibliographic Details
Main Authors: Vaishnaw, Akshay (Author) , Krammer, Peter H. (Author)
Format: Article (Journal)
Language:English
Published: February 1, 1999
In: The journal of clinical investigation
Year: 1999, Volume: 103, Issue: 3, Pages: 355-363
ISSN:1558-8238
DOI:10.1172/JCI5121
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1172/JCI5121
Verlag, lizenzpflichtig, Volltext: https://www.jci.org/articles/view/5121
Get full text
Author Notes:Akshay K. Vaishnaw, Jason R. Orlinick, Jia-Li Chu, Peter H. Krammer, Moses V. Chao, and Keith B. Elkon

MARC

LEADER 00000caa a2200000 c 4500
001 1755857608
003 DE-627
005 20230428043037.0
007 cr uuu---uuuuu
008 210423s1999 xx |||||o 00| ||eng c
024 7 |a 10.1172/JCI5121  |2 doi 
035 |a (DE-627)1755857608 
035 |a (DE-599)KXP1755857608 
035 |a (OCoLC)1341405835 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Vaishnaw, Akshay  |e VerfasserIn  |0 (DE-588)1232102873  |0 (DE-627)1755858809  |4 aut 
245 1 4 |a The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations  |c Akshay K. Vaishnaw, Jason R. Orlinick, Jia-Li Chu, Peter H. Krammer, Moses V. Chao, and Keith B. Elkon 
264 1 |c February 1, 1999 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.04.2021 
520 |a Heterozygous mutations of the receptor CD95 (Fas/Apo-1) are associated with defective lymphocyte apoptosis and a clinical disease characterized by lymphadenopathy, splenomegaly, and systemic autoimmunity. From our cohort of 11 families, we studied eight patients to define the mechanisms responsible for defective CD95-mediated apoptosis. Mutations in and around the death domain of CD95 had a dominant–negative effect that was explained by interference with the recruitment of the signal adapter protein, FADD, to the death domain. The intracellular domain (ICD) mutations were associated with a highly penetrant Canale-Smith Syndrome (CSS) phenotype and an autosomal dominant inheritance pattern. In contrast, mutations affecting the CD95 extracellular domain (ECD) resulted in failure of extracellular expression of the mutant protein or impaired binding to CD95 ligand. They did not have a dominant–negative effect. In each of the families with an ECD mutation, only a single individual was affected. These observations were consistent with differing mechanisms of action and modes of inheritance of ICD and ECD mutations, suggesting that individuals with an ECD mutation may require additional defect(s) for expression of CSS. 
700 1 |a Krammer, Peter H.  |d 1946-  |e VerfasserIn  |0 (DE-588)121766373  |0 (DE-627)081520255  |0 (DE-576)292873417  |4 aut 
773 0 8 |i Enthalten in  |t The journal of clinical investigation  |d Ann Arbor, Mich. : ASCJ, 1924  |g 103(1999), 3, Seite 355-363  |h Online-Ressource  |w (DE-627)316004677  |w (DE-600)2018375-6  |w (DE-576)094950423  |x 1558-8238  |7 nnas  |a The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations 
773 1 8 |g volume:103  |g year:1999  |g number:3  |g pages:355-363  |g extent:9  |a The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations 
856 4 0 |u https://doi.org/10.1172/JCI5121  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.jci.org/articles/view/5121  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210423 
993 |a Article 
994 |a 1999 
998 |g 121766373  |a Krammer, Peter H.  |m 121766373:Krammer, Peter H.  |d 50000  |e 50000PK121766373  |k 0/50000/  |p 4 
999 |a KXP-PPN1755857608  |e 3915142492 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Akshay K. Vaishnaw, Jason R. Orlinick, Jia-Li Chu, Peter H. Krammer, Moses V. Chao, and Keith B. Elkon"]},"id":{"doi":["10.1172/JCI5121"],"eki":["1755857608"]},"origin":[{"dateIssuedDisp":"February 1, 1999","dateIssuedKey":"1999"}],"relHost":[{"title":[{"title_sort":"journal of clinical investigation","title":"The journal of clinical investigation","subtitle":"JCI ; the publication of the American Society for Clinical Investigation"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutationsThe journal of clinical investigation","note":["Gesehen am 25.01.2022","Fortsetzung der Druck-Ausgabe"],"recId":"316004677","corporate":[{"display":"American Society for Clinical Investigation","roleDisplay":"Herausgebendes Organ","role":"isb"}],"language":["eng"],"pubHistory":["1.1924/25 -"],"titleAlt":[{"title":"JCI"}],"part":{"year":"1999","issue":"3","pages":"355-363","volume":"103","text":"103(1999), 3, Seite 355-363","extent":"9"},"origin":[{"dateIssuedKey":"1924","publisher":"ASCJ","dateIssuedDisp":"1924-","publisherPlace":"Ann Arbor, Mich."}],"id":{"issn":["1558-8238"],"zdb":["2018375-6"],"eki":["316004677"]},"physDesc":[{"extent":"Online-Ressource"}]}],"physDesc":[{"extent":"9 S."}],"person":[{"given":"Akshay","family":"Vaishnaw","role":"aut","roleDisplay":"VerfasserIn","display":"Vaishnaw, Akshay"},{"roleDisplay":"VerfasserIn","display":"Krammer, Peter H.","role":"aut","family":"Krammer","given":"Peter H."}],"title":[{"title_sort":"molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations","title":"The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations"}],"language":["eng"],"recId":"1755857608","note":["Gesehen am 23.04.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a VAISHNAWAKMOLECULARB1199 

Similar Items